1 |
Cui K, Gao X, Wang B, Wu H, Arulsamy K, Dong Y, Xiao Y, Jiang X, Malovichko MV, Li K, Peng Q, Lu YW, Zhu B, Zheng R, Wong S, Cowan DB, Linton M, Srivastava S, Shi J, Chen K, Chen H. Epsin Nanotherapy Regulates Cholesterol Transport to Fortify Atheroma Regression. Circ Res 2023;132:e22-42. [PMID: 36444722 DOI: 10.1161/CIRCRESAHA.122.321723] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
2 |
Dong Y, Wang B, Du M, Zhu B, Cui K, Chan K, Cowan DB, Bhattacharjee S, Wong S, Bischoff J, Linton MF, Chen H. Targeting Epsins to Inhibit FGF Signaling while Potentiating TGF-β Signaling Constrains Endothelial-to-Mesenchymal-Transition in Atherosclerosis.. [DOI: 10.1101/2022.08.09.503324] [Reference Citation Analysis]
|
3 |
Cui K, Gao X, Wang B, Wu H, Dong Y, Xiao Y, Jiang X, Malovichko MV, Li K, Peng Q, Lu Y, Zhu B, Zheng R, Wong S, Cowan DB, Linton M, Srivastava S, Shi J, Chen K, Chen H. Targeting Epsins by nanotherapy regulates lipid metabolism and promotes ABCG1-mediated cholesterol efflux to fortify atheroma regression.. [DOI: 10.1101/2022.08.09.503334] [Reference Citation Analysis]
|